Solana Co — Director's Dealing 2015

Oct 23, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HELIUS MEDICAL TECHNOLOGIES, INC. (HSDT)
CIK: 0001610853
Period of Report: 2015-10-21

Reporting Person: LaViscount Joyce N (Director, CFO and COO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-10-21	Stock Option (Right to Buy)	$.67	A	750000	Acquired	2020-10-21	Class A Common Stock (750000)	Direct

Footnotes

F1: Translated into U.S. dollars from Canadian dollars based on the noon buying rate from the Federal Reserve Bank of USD$1.00 = CAD$1.2932 on October 16, 2015, based on an option exercise price of CAD$0.87.

F2: Twenty-five percent of the shares subject to this option vested on the grant date. An additional 25% of the shares subject to this option will vest every six months.